Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: A randomized controlled study

Cardiovascular Drugs and Therapy

Volumn 17, Issue 1, 2003, Pages 31-39

  Manios, Emmanuel G ^a   Mavrakis, Hercules E ^a   Kanoupakis, Emmanuel M ^a   Kallergis, Eleftherios M ^a   Dermitzaki, Despina N ^a   Kambouraki, Despina C ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Amiodarone; Atrial fibrillation; Diltiazem; Recurrence; Remodeling

Indexed keywords

AMIODARONE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DILTIAZEM;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTRICAL REMODELING; FEMALE; FIBRILLATORY CYCLE LENGTH; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE REFRACTORY PERIOD; HUMAN; INTERNAL CARDIOVERSION; MAJOR CLINICAL STUDY; MALE; PERSISTENT HEART ATRIUM FIBRILLATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SINUS RHYTHM; SUPRAVENTRICULAR PREMATURE BEAT;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CHRONIC DISEASE; DILTIAZEM; ELECTRIC COUNTERSHOCK; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE;

EID: 0041846770     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024203824761     Document Type: Article

References (40)

1. Morillo C, Klein G, Jones DL, Guiraurdon CM. Chronic rapid atrial pacing: Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995;91:1588-1595.
2. Wijffels MCEF, Kirchoff CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
3. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:2968-2974.
4. Daoud EG, Bogun F, Goyal R, et al. Effect of AF on atrial refractoriness in humans. Circulation 1996;94:1600-1606.
5. Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: Roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 1997;96:3710-3720.
6. Gaspo R, Bosch RF, Talajic M, Nattel S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation 1997;96:4027-4035.
7. Bosch R, Zeng X, Grammer J, Popovic K, Mewis C, Kuhlkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 1999;44:121-131.
8. 2+-ATPase mRNA in human atrial fibrillation without significant change in the m RNA of ryanodine receptor, calsequestrin and phospholamban. J Am Coll Cardiol 1999;33:1231-1237.
9. Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation 1998;98:2202-2209.
10. Allessie MA. Atrial electrophysiological remodeling: Another vicious circle? J Cardiovasc Electrophysiol 1998;9:1378-1393.
11. Nattel S. Atrial electrophysiological remodeling caused by rapid atrial activation: Underlying mechanisms and clinical relevance to atrial fibrillation. Cardiovasc Res 1999;42:298-308.
12. Yu W, Lee SH, Tai CT, et al. Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res 1999;42:470-476.
13. Lee SH LF, Yu WC, Cheng JJ, et al. Regional differences in the recovery course of tachycardia induced changes of atrial electrophysiological properties. Circulation 1999;99:1255-1264.
14. Manios E, Kanoupakis E, Chlouverakis G, Kaleboubas M, Mavrakis H, Vardas P. Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: Relation with recurrence. Cardiovasc Res 2000;47:244-253.
15. Tieleman RG, De Langen C, Van Gelder IC, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997;95:1945-1953.
16. Daoud EG, Knight BP, Weiss R, et al. Effect of Verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation 1997;96:1542-1550.
17. Tieleman RG, Van Gelder IC, Crijns HJ, et al. Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998;31:167-173.
18. De Simone A, Stabile G, Vitale DF, et al. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol 1999;34:810-814.
19. Botto GL, Belotti G, Romano M, et al. Verapamil pretreatment before electrical cardioversion of persistent atrial fibrillation: The VERAF study. Eur Heart J 2001;22:329 (abstr).
20. Van Noord T, Van Gelder IC, Tieleman RG, et al. VERDICT: The verapamil versus digoxin cardioversion trial: A randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2001;12:766-769.
21. Villani GQ, Piepoli MF, Terracciano C, Capucci A. Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: A single-blind, randomized, controlled study. Am Heart J 2000;140:437-443.
22. Tieleman RG, Gosselink AT, Crijns HJGM, et al. Efficacy safety and determinants of conversion of atrial fibrillation and flutter with oral amiodarone. Am J Cardiol 1997;79:53-57.
23. Kerin NZ, Faitel K, Naini M. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Arch Intern Med 1996;156:49-53.
24. Gosselink AT, Crijns HJGM, van Gelder IC, et al. Low dose amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation or flutter. JAMA 1992;267:3289-3293.
25. Capucci A, Villani GQ, Aschieri D, Rosi A, Piepoli MF. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J 2000;21:66-73.
26. Vardas P, Kochiadakis G, Igoumenidis N, Tsatsakis A, Simantirakis E, Chlouverakis G. Amiodarone as a first choice drug for restoring sinus rhythm in patients with atrial fibrillation. Chest 2000;117:1538-1545.
27. Gaita F, Riccardi R, Calo L, et al. Atrial mapping and radiofrequency catheter ablation in patients with idiopathic atrial fibrillation. Electrophysiological findings and ablation results. Circulation 1998;97:2136-2145.
28. Josephson M. Clinical Cardiac Electrophysiology: Techniques and Interpretations, 2nd ed. Philadelphia: Lea & Febiger, 1993:22-70.
29. Lee SH, Yu WC, Cheng JJ, et al. effect of verapamil on long term tachycardia induced atrial electrical remodeling. Circulation 2000;101:200-206.
30. Fareh S, Benardeau A, Natel S. Differential efficacy of L-type and T-type calcium channel blockers in preventing tachycardia induced atrial remodeling in dogs. Cardiovasc Res 2001;49:762-770.
31. Pandozi C, Bianconi L, Calo L, et al. Postcardioversion atrial electrophysiologic changes induced by oral verapamil in patients with persistent atrial fibrillation. J Am Coll Cardiol 2000;36:2234-2241.
32. Kurita Y, Mitamura H, Shiroshita-Takeshita A, et al. Daily oral verapamil before but not after rapid atrial excitation prevents electrical remodeling. Cardiovasc Res 2002;54:447-455.
33. Villani GQ, Piepoli MF, Marrazzo N, Capucci A. Electrophysiologic effect of amiodarone pre-treatment in persistent atrial fibrillation patients. J Am Coll Cardiol 2001;37:1A (abstr).
34. Asano Y, Saito J, Matsumoto K, et al. On the mechanism of termination and perpetuation of atrial fibrillation. Am J Cardiol 1992;69:1033-1038.
35. Haissaguerre M, Jais P, Shah DC, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997;95:572-576.
36. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-666.
37. Chen S-A, Hsieh M-S, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses and effects of radiofrequency ablation. Circulation 1999;100:1879-1886.
38. Waktare JEP, Hnatkova K, Sopher M, et al. The role of atrial ectopics in initiating paroxysms of atrial fibrillation. Eur Heart J 2001;22:333-339.
39. Manios E, Kanoupakis E, Mavrakis H, Kallergis E, Dermitzaki D, Vardas P. Sinus pacemaker function after cardioversion of chronic atrial fibrillation: Is sinus node remodeling related with recurrence? J Cardiovasc Electrophysiol 2001;12:800-806.
40. Sharpe MD, Dobkowski WB, Murkin JM, Klein G, Yee R. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory path-way conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia. Anesthesiology 1995;82:888-895.